Physician profile
Michael D Chidester
NPI 1629024435
$1,783.78
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $304 · 2021: $417 · 2022: $431 · 2023: $256 · 2024: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $458.60 | 2019-2024 | |
| Abbvie INC. | $202.79 | 2021-2024 | Vraylar |
| Novartis Pharmaceuticals Corporation | $154.24 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.98 | 2019-2023 | Xifaxan |
| Allergan, INC. | $113.03 | 2020 | |
| Lilly USA, LLC | $108.14 | 2020-2022 | |
| Novo Nordisk INC | $106.26 | 2019-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $105.77 | 2020-2023 | |
| Glaxosmithkline, LLC. | $86.33 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $59.84 | 2021-2022 | |
| Abbott Laboratories | $44.35 | 2021-2022 | |
| Eisai INC. | $40.04 | 2020-2021 | |
| Exact Sciences Corporation | $37.64 | 2023-2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $35.30 | 2020-2021 | |
| Abiomed | $22.51 | 2024 | Impella |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $21.61 | 2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.07 | 2019 | |
| Amgen INC. | $18.28 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chidester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.